Literature DB >> 21512641

MSC - a Multipotent Stromal Cell in Search of Clinical Application.

Torsten Tonn1, Dagmar Barz.   

Abstract

Entities:  

Year:  2008        PMID： 21512641      PMCID： PMC3076358          DOI： 10.1159/000147276

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN： 1660-3796            Impact factor:   3.747


× No keyword cloud information.
  11 in total

1.  Multipotent Mesenchymal Stromal Cells for Autoimmune Diseases.

Authors:  Alan Tyndall
Journal:  Transfus Med Hemother       Date:  2008-07-17       Impact factor: 3.747

2.  Current Regulations for the Production of Multipotent Mesenchymal Stromal Cells for Clinical Application.

Authors:  Ineke C M Slaper-Cortenbach
Journal:  Transfus Med Hemother       Date:  2008-07-21       Impact factor: 3.747

3.  Homing of Mesenchymal Stem Cells.

Authors:  Reinhard Henschler; Erika Deak; Erhard Seifried
Journal:  Transfus Med Hemother       Date:  2008-07-21       Impact factor: 3.747

4.  Changes of the Functional Capacity of Mesenchymal Stem Cells due to Aging or Age-Associated Disease - Implications for Clinical Applications and Donor Recruitment.

Authors:  Günter Lepperdinger; Regina Brunauer; Robert Gassner; Angelika Jamnig; Frank Kloss; Gerhard Thomas Laschober
Journal:  Transfus Med Hemother       Date:  2008-07-17       Impact factor: 3.747

5.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

Authors:  Katarina Le Blanc; Ida Rasmusson; Berit Sundberg; Cecilia Götherström; Moustapha Hassan; Mehmet Uzunel; Olle Ringdén
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

6.  Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

Authors:  E M Horwitz; K Le Blanc; M Dominici; I Mueller; I Slaper-Cortenbach; F C Marini; R J Deans; D S Krause; A Keating
Journal:  Cytotherapy       Date:  2005       Impact factor: 5.414

7.  Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells.

Authors:  Karen Bieback; Katharina Schallmoser; Harald Klüter; Dirk Strunk
Journal:  Transfus Med Hemother       Date:  2008-07-17       Impact factor: 3.747

8.  Mesenchymal Stem Cells - Sources and Clinical Applications.

Authors:  Hans Klingemann; David Matzilevich; James Marchand
Journal:  Transfus Med Hemother       Date:  2008-07-21       Impact factor: 3.747

9.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

Authors:  Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roelofs; Ian Lewis; Edoardo Lanino; Berit Sundberg; Maria Ester Bernardo; Mats Remberger; Giorgio Dini; R Maarten Egeler; Andrea Bacigalupo; Willem Fibbe; Olle Ringdén
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

Review 10.  Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005.

Authors:  Alan Tyndall; Ulrich A Walker; Andrew Cope; Francesco Dazzi; Cosimo De Bari; Willem Fibbe; Serena Guiducci; Simon Jones; Christian Jorgensen; Katarina Le Blanc; Frank Luyten; Dennis McGonagle; Ivan Martin; Chiara Bocelli-Tyndall; Giuseppina Pennesi; Vito Pistoia; Constantino Pitzalis; Antonio Uccelli; Nico Wulffraat; Marc Feldmann
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156
View more
  2 in total

Review 1.  Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures.

Authors:  Karen Bieback
Journal:  Transfus Med Hemother       Date:  2013-08-26       Impact factor: 3.747

2.  Mitigation of Lethal Radiation Syndrome in Mice by Intramuscular Injection of 3D Cultured Adherent Human Placental Stromal Cells.

Authors:  Elena Gaberman; Lena Pinzur; Lilia Levdansky; Maria Tsirlin; Nir Netzer; Zami Aberman; Raphael Gorodetsky
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.